Trump Administration Abandons Hospital Rule Targeting Transgender Youth Care

In early December 2024 the Department of Health and Human Services (HHS) issued a draft rule that would have barred any hospital providing puberty blockers, hormone therapy, or gender-transition surgeries to patients under 18 from participating in Medicare and Medicaid. The rule never took effect; on Monday, HHS announced it would not move forward with the proposal after a public comment period that generated more than 30,000 submissions.

Human Rights Campaign

The rule was part of a broader strategy by the Trump administration to restrict gender-affirming care for minors. Separate proposals already aim to prevent Medicaid and the Children’s Health Insurance Program (CHIP) from covering such care. The abandoned rule would have leveraged “conditions of participation”—standards normally used to ensure hospital safety—to punish providers of transgender health services, threatening funding for all patients served by the hospitals, including older adults and low-income individuals.

The AdvocateHuman Rights Campaign

• Sam Bagenstos, University of Michigan law professor and former HHS general counsel, explained the rarity of a full withdrawal after a notice-and-comment process.

The Advocate

• Kelley Robinson, President of the Human Rights Campaign (HRC), framed the reversal as a product of mass public outrage.

The Advocate

• Tony Hoang, Executive Director of Equality California, called the outcome a “hard-fought victory.”

The Advocate

• Adrian Shanker, former deputy assistant secretary for health policy at HHS, highlighted the distortion of Medicaid and CHIP policy.

The Advocate

• Major medical organizations—including the American Medical Association, the American Academy of Pediatrics, and the Children’s Hospital Association—publicly urged the administration to drop the rule.

The Advocate

• Over 30,000 comments were submitted to the Centers for Medicare & Medicaid Services (CMS).

The Advocate

• Nearly 20,000 of those comments originated from HRC members and supporters.

The Advocate

• The rule would have affected virtually every U.S. hospital, given universal participation in Medicare and Medicaid.

The Advocate

HRC President Kelley Robinson said the administration’s retreat demonstrated that “mass public engagement can still produce results.” Equality California’s Tony Hoang described the decision as a “hard-fought victory” resulting from sustained advocacy. Adrian Shanker emphasized that the proposal represented a “profound distortion of programs intended to expand access to medical care” and warned that hospitals that pre-emptively halted services suffered “significant damage.” Legal scholars, including Bagenstos, noted that the extensive comment record creates a stronger basis for any future litigation and forces agencies to justify policies with concrete evidence.

The Advocate

Advocates caution that the reversal does not restore care in states where gender-affirming treatment remains banned, nor does it undo the harm caused by hospitals that stopped services in anticipation of the rule. Shanker labeled pre-emptive compliance as “wrong,” urging hospitals in permissive states to resume care. Critics also point to the administration’s continued pursuit of separate payment-restriction proposals as evidence that the overall policy agenda remains hostile toward transgender youth.

The Advocate

• “It’s pretty rare for an agency to go to all the trouble of issuing a notice of proposed rulemaking and then decide they’re just not going to do anything,” — Sam Bagenstos, University of Michigan law professor

The Advocate

• “Sometimes the comments come in, and it’s just overwhelmingly clear that the rule that they want to propose is indefensible,” — Sam Bagenstos

The Advocate

• “It takes an avalanche of outrage to stop this administration from doing harm to innocent people, and together, we the people delivered to protect transgender youth across the country.” — Kelley Robinson, President, Human Rights Campaign

Human Rights Campaign

• “Make no mistake, this is a reprieve, not a victory, and only for some.” — Kelley Robinson

Human Rights Campaign

• “Public comments do matter in the regulatory process,” — Adrian Shanker, former HHS deputy assistant secretary for health policy

The Advocate

• “I think their decisions to comply in advance are wrong,” — Adrian Shanker

The Advocate

The administration continues to advance a separate rule that would prohibit Medicaid and CHIP from covering transition-related care for minors. Advocates plan to file additional comments and prepare legal challenges, emphasizing that each proposed regulation remains vulnerable to judicial review.

The Advocate